231 related articles for article (PubMed ID: 12895129)
1. Abdominal adipose tissue distribution and metabolic risk.
Wong S; Janssen I; Ross R
Sports Med; 2003; 33(10):709-26. PubMed ID: 12895129
[TBL] [Abstract][Full Text] [Related]
2. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots.
Misra A; Vikram NK
Nutrition; 2003 May; 19(5):457-66. PubMed ID: 12714101
[TBL] [Abstract][Full Text] [Related]
4. Body fat distribution in pre- and post-menopausal women: metabolic and anthropometric variables and their inter-relationships.
Zamboni M; Armellini F; Milani MP; De Marchi M; Todesco T; Robbi R; Bergamo-Andreis IA; Bosello O
Int J Obes Relat Metab Disord; 1992 Jul; 16(7):495-504. PubMed ID: 1323546
[TBL] [Abstract][Full Text] [Related]
5. Abdominal adiposity and insulin resistance in obese men.
Ross R; Aru J; Freeman J; Hudson R; Janssen I
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E657-63. PubMed ID: 11832370
[TBL] [Abstract][Full Text] [Related]
6. [Visceral, subcutaneous or intramuscular fat: where is the problem?].
Hermsdorff HH; Monteiro JB
Arq Bras Endocrinol Metabol; 2004 Dec; 48(6):803-11. PubMed ID: 15761553
[TBL] [Abstract][Full Text] [Related]
7. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
8. Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?
Paré A; Dumont M; Lemieux I; Brochu M; Alméras N; Lemieux S; Prud'homme D; Després JP
Obes Res; 2001 Sep; 9(9):526-34. PubMed ID: 11557833
[TBL] [Abstract][Full Text] [Related]
9. Detrimental and protective fat: body fat distribution and its relation to metabolic disease.
Booth A; Magnuson A; Foster M
Horm Mol Biol Clin Investig; 2014 Jan; 17(1):13-27. PubMed ID: 25372727
[TBL] [Abstract][Full Text] [Related]
10. Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes.
Franssens BT; Westerink J; van der Graaf Y; Nathoe HM; Visseren FLJ;
Int J Cardiol; 2016 Nov; 222():72-77. PubMed ID: 27458826
[TBL] [Abstract][Full Text] [Related]
11. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
You T; Yang R; Lyles MF; Gong D; Nicklas BJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
[TBL] [Abstract][Full Text] [Related]
12. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
Hill JH; Solt C; Foster MT
Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
[TBL] [Abstract][Full Text] [Related]
13. Cardiorespiratory fitness is associated with lower abdominal fat independent of body mass index.
Wong SL; Katzmarzyk P; Nichaman MZ; Church TS; Blair SN; Ross R
Med Sci Sports Exerc; 2004 Feb; 36(2):286-91. PubMed ID: 14767252
[TBL] [Abstract][Full Text] [Related]
14. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
[TBL] [Abstract][Full Text] [Related]
15. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women.
Lee K; Lee S; Kim YJ; Kim YJ
Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667
[TBL] [Abstract][Full Text] [Related]
16. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes.
Liu KH; Chan YL; Chan WB; Kong WL; Kong MO; Chan JC
Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1267-73. PubMed ID: 14513076
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.
Wajchenberg BL
Endocr Rev; 2000 Dec; 21(6):697-738. PubMed ID: 11133069
[TBL] [Abstract][Full Text] [Related]
18. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women.
Dozio E; Briganti S; Delnevo A; Vianello E; Ermetici F; Secchi F; Sardanelli F; Morricone L; Malavazos AE; Corsi Romanelli MM
Eur J Nutr; 2017 Dec; 56(8):2557-2564. PubMed ID: 27522371
[TBL] [Abstract][Full Text] [Related]
19. Visceral fat and liver fat are independent predictors of metabolic risk factors in men.
Nguyen-Duy TB; Nichaman MZ; Church TS; Blair SN; Ross R
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1065-71. PubMed ID: 12554597
[TBL] [Abstract][Full Text] [Related]
20. Association of visceral adipose tissue with incident myocardial infarction in older men and women: the Health, Aging and Body Composition Study.
Nicklas BJ; Penninx BW; Cesari M; Kritchevsky SB; Newman AB; Kanaya AM; Pahor M; Jingzhong D; Harris TB;
Am J Epidemiol; 2004 Oct; 160(8):741-9. PubMed ID: 15466496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
